Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2009-06-12
2011-11-29
O Dell, David K (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C544S333000, C546S273400, C514S333000, C514S256000
Reexamination Certificate
active
08067606
ABSTRACT:
The present invention relates to methods of treating, preventing, or lessening the severity of resistant bacterial infections in mammals, utilizing compounds of formula I or formula VII or pharmaceutically salts thereof. The present invention also relates to methods of using compounds of formula I or formula VII in combination with one or more additional antibacterial agents and/or one or more additional therapeutic agents that increase the susceptibility of bacterial organisms to antibiotics.
REFERENCES:
patent: 4174400 (1979-11-01), Myozik
patent: 4512998 (1985-04-01), Natiss-Verchei
patent: 5529998 (1996-06-01), Habich et al.
patent: 5643935 (1997-07-01), Dykstra et al.
patent: 6632809 (2003-10-01), Grillot et al.
patent: RE40245 (2008-04-01), Grillot et al.
patent: 7414046 (2008-08-01), Grillot et al.
patent: 7495014 (2009-02-01), Charifson et al.
patent: 7569591 (2009-08-01), Charifson et al.
patent: 7582641 (2009-09-01), Charifson et al.
patent: 7618974 (2009-11-01), Charifson et al.
patent: 7727992 (2010-06-01), Charifson et al.
patent: 2004/0043989 (2004-03-01), Grillot et al.
patent: 2005/0038247 (2005-02-01), Charifson et al.
patent: 2009/0176771 (2009-07-01), Charifson et al.
patent: 2009/0325935 (2009-12-01), Charifson et al.
patent: 2010/0063069 (2010-03-01), Charifson et al.
patent: 0433648 (1991-06-01), None
patent: 0738726 (1996-10-01), None
patent: 1055668 (2000-11-01), None
patent: 99/35155 (1999-07-01), None
patent: 0049015 (2000-08-01), None
patent: 00/71522 (2000-11-01), None
patent: 02/060879 (2002-08-01), None
patent: 03/105846 (2003-12-01), None
patent: 2005/012292 (2005-01-01), None
patent: 2006022773 (2006-03-01), None
patent: 2007056330 (2007-05-01), None
Skopenko, V.V., et al., “Organotin Carbamoyldicyanomethanide, nitrosocarbamoylcyanomethanide, and carbamoylcyanides”, retrived from STN Database accession No. 101230674, XP002254350 abstract and Dopovidi Akedemi Nauk Ukrains Koi RSR, Seriya B: Geologichni, Khimichini Ta Biologichni Nauki, 7:44-46(1984).
Hubschwerlen et al. “Pyrimido (1,6-a]benzimidazoles: A New Class of DNA Gyrase Inhibitors” J. Med. Chem., vol. 35, No. 8 pp. 1385-1392, 1992.
Sun et al., “Synthesis and Evaluation of Terbenzimidazoles as Topoisomerase I Inhibitors”J. Med. Chem., vol. 38, No. 18, pp. 3638-3644 (1995).
Kus et al., “Synthesis and Antimicrobial Activities of 5-fluoro 1,2,6-trisubstituted Benzimidazole Carboxamide and Acetamide Derivatives” Arch. Pharm. Pharm. Med. Chem., vol. 334, No. 11, pp. 361-365, 2001.
Singh S.K. et al., “Studies in antiparasitic agents: Part 13—Synthesis of 4-arul-2 substiutedamino-thiazoles as potential anthelminitics.” Indian J. Chem., 28B (9): 786-789 (1989).
Nicolaus B.J.R., “Symbiotic Approach to Drug Design” Decision Making in Drug Research, pp. 173-186 (1983).
Tanitame et al. “Design synthesis and structure-activity relationship studies of novel indazole analogues as DNA gyrase inhibitors with Gram-positive antibacterial activity ”Bioorganic & Medicinal Chemistry Letters 2004, 14, 2857-2862.
Guven et al. “Synthesis and Antimicrobial Activity of Some novel Furyl and Benzimidazole Substituted Benzyl Ethers” Journal of Heterocylcic Chemistry 2007, 44, 731.
He et al. “Synthesis and biological evaluations of novel benzimidazoles as potential antibacterial agents.” Bioorganic & Medicinal Chemistry Letters 2004, 14, 1217-1220.
Charifson Paul
Deininger David
Drumm Joseph
Grillot Anne-Laure
LeTiran Arnaud
Badia Michael C.
Dell David K O
Vertex Pharmaceuticals Incorporated
LandOfFree
Gyrase inhibitors and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Gyrase inhibitors and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gyrase inhibitors and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4278981